Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

18F-DCFPyL PET/CT Imaging in Patients with Biochemical Recurrence Prostate Cancer after Primary Local Therapy.

Mena E, Lindenberg ML, Turkbey IB, Shih JH, Harmon SA, Lim I, Lin FI, Adler S, Eclarinal P, McKinney Y, Citrin D, Dahut W, Wood B, Krishnasamy V, Chang R, Levy E, Merino M, Pinto P, Eary JF, Choyke PL.

J Nucl Med. 2019 Nov 1. pii: jnumed.119.234799. doi: 10.2967/jnumed.119.234799. [Epub ahead of print]

PMID:
31676732
2.

Human Radiation Dosimetry of Orally or Intravenously Administered 18F-Fluorodeoxyglucose.

Srinivasan S, Crandall J, Gajwani P, Sgouros G, Mena E, Lodge MA, Wahl RL.

J Nucl Med. 2019 Oct 18. pii: jnumed.119.233288. doi: 10.2967/jnumed.119.233288. [Epub ahead of print]

PMID:
31628217
3.

18F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab.

Lim I, Lindenberg ML, Mena E, Verdini N, Shih JH, Mayfield C, Thompson R, Lin J, Vega A, Mallek M, Cadena J, Diaz C, Mortazavi A, Knopp M, Wright C, Stein M, Pal S, Choyke PL, Apolo AB.

Eur J Nucl Med Mol Imaging. 2019 Sep 14. doi: 10.1007/s00259-019-04483-5. [Epub ahead of print]

PMID:
31522271
4.

Protein compounds of Bacillus subtilis with in vitro antifungal activity against Pseudocercospora fijiensis (Morelet).

Cruz-Martín M, Mena E, Acosta-Suárez M, Pichardo T, Rodriguez E, Alvarado-Capó Y.

Braz J Microbiol. 2019 Aug 16. doi: 10.1007/s42770-019-00136-9. [Epub ahead of print]

PMID:
31418142
5.

New Targets for PET Molecular Imaging of Prostate Cancer.

Mena E, Lindenberg LM, Choyke PL.

Semin Nucl Med. 2019 Jul;49(4):326-336. doi: 10.1053/j.semnuclmed.2019.02.001. Epub 2019 Mar 9. Review.

PMID:
31227055
6.

Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis.

Yang YM, Noureddin M, Liu C, Ohashi K, Kim SY, Ramnath D, Powell EE, Sweet MJ, Roh YS, Hsin IF, Deng N, Liu Z, Liang J, Mena E, Shouhed D, Schwabe RF, Jiang D, Lu SC, Noble PW, Seki E.

Sci Transl Med. 2019 Jun 12;11(496). pii: eaat9284. doi: 10.1126/scitranslmed.aat9284.

PMID:
31189722
7.

Effect of Weight Loss after Bariatric Surgery on Thyroid-Stimulating Hormone Levels in Euthyroid Patients with Morbid Obesity.

Juiz-Valiña P, Outeiriño-Blanco E, Pértega S, Varela-Rodriguez BM, García-Brao MJ, Mena E, Pena-Bello L, Cordido M, Sangiao-Alvarellos S, Cordido F.

Nutrients. 2019 May 20;11(5). pii: E1121. doi: 10.3390/nu11051121.

8.

First-in-human phase 0 study of 111In-CHX-A"-DTPA trastuzumab for HER2 tumor imaging.

Kurdziel KA, Mena E, McKinney Y, Wong K, Adler S, Sissung T, Lee J, Lipkowitz S, Lindenberg L, Turkbey B, Kummar S, Milenic DE, Doroshow JH, Figg WD, Merino MJ, Paik CH, Brechbiel MW, Choyke PL.

J Transl Sci. 2019 Apr;5(2). doi: 10.15761/JTS.1000269. Epub 2018 Jul 13.

9.

Novel Imaging in Detection of Metastatic Prostate Cancer.

Smith CP, Laucis A, Harmon S, Mena E, Lindenberg L, Choyke PL, Turkbey B.

Curr Oncol Rep. 2019 Mar 5;21(4):31. doi: 10.1007/s11912-019-0780-8. Review.

PMID:
30834999
10.

Imaging of Prostate Specific Membrane Antigen Targeted Radiotracers for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis.

Tan N, Bavadian N, Calais J, Oyoyo U, Kim J, Turkbey IB, Mena E, Davenport MS.

J Urol. 2019 Aug;202(2):231-240. doi: 10.1097/JU.0000000000000198. Epub 2019 Jul 8.

PMID:
30829130
11.

Real-world GLP-1 RA therapy in type 2 diabetes: A long-term effectiveness observational study.

Tofé S, Argüelles I, Mena E, Serra G, Codina M, Urgeles JR, García H, Pereg V.

Endocrinol Diabetes Metab. 2018 Nov 19;2(1):e00051. doi: 10.1002/edm2.51. eCollection 2019 Jan.

12.

Practical strategies for pruritus management in the obeticholic acid-treated patient with PBC: proceedings from the 2018 expert panel.

Pate J, Gutierrez JA, Frenette CT, Goel A, Kumar S, Manch RA, Mena EA, Pockros PJ, Satapathy SK, Yimam KK, Gish RG.

BMJ Open Gastroenterol. 2019 Feb 1;6(1):e000256. doi: 10.1136/bmjgast-2018-000256. eCollection 2019.

13.

PET imaging in renal cancer.

Lindenberg L, Mena E, Choyke PL, Bouchelouche K.

Curr Opin Oncol. 2019 May;31(3):216-221. doi: 10.1097/CCO.0000000000000518.

PMID:
30747736
14.

A comparison of prostate cancer bone metastases on 18F-Sodium Fluoride and Prostate Specific Membrane Antigen (18F-PSMA) PET/CT: Discordant uptake in the same lesion.

Harmon SA, Mena E, Shih JH, Adler S, McKinney Y, Bergvall E, Mehralivand S, Sowalsky AG, Couvillon A, Madan RA, Gulley JL, Eary J, Mease RC, Pomper MG, Dahut WL, Turkbey B, Lindenberg L, Choyke PL.

Oncotarget. 2018 Dec 28;9(102):37676-37688. doi: 10.18632/oncotarget.26481. eCollection 2018 Dec 28.

15.

[AdvanceGender-Joint project for sex/gender-sensitive and intersectional research and health reporting].

Pöge K, Rommel A, Mena E, Holmberg C, Saß AC, Bolte G.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Jan;62(1):102-107. doi: 10.1007/s00103-018-2855-3. Review. German.

PMID:
30498848
16.

Keeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agents.

Czarniecki M, Mena E, Lindenberg L, Cacko M, Harmon S, Radtke JP, Giesel F, Turkbey B, Choyke PL.

Transl Androl Urol. 2018 Oct;7(5):831-843. doi: 10.21037/tau.2018.08.03. Review.

17.

Genome-wide analysis of the soybean CRK-family and transcriptional regulation by biotic stress signals triggering plant immunity.

Delgado-Cerrone L, Alvarez A, Mena E, Ponce de León I, Montesano M.

PLoS One. 2018 Nov 15;13(11):e0207438. doi: 10.1371/journal.pone.0207438. eCollection 2018.

18.

Does Angiotensin Receptor Neprilysin Inhibitor (ARNI) Improve Functional Capacity Assessed by 6 Minutes Walking Test?

Faraudo M, Beltran P, Freixa R, Mena E, Guri O, Contra A, Ceresuela LM, Masip J.

Eur Cardiol. 2017 Dec;12(2):100. doi: 10.15420/ecr.2017:23:9. No abstract available.

19.

Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Solid Tumors.

Young CR, Adler S, Eary JF, Lindenberg ML, Jacobs PM, Collins J, Kummar S, Kurdziel KA, Choyke PL, Mena E.

J Nucl Med. 2019 Apr;60(4):492-496. doi: 10.2967/jnumed.118.216994. Epub 2018 Nov 2.

20.

Dimerization quality control ensures neuronal development and survival.

Mena EL, Kjolby RAS, Saxton RA, Werner A, Lew BG, Boyle JM, Harland R, Rape M.

Science. 2018 Oct 12;362(6411). pii: eaap8236. doi: 10.1126/science.aap8236. Epub 2018 Sep 6.

PMID:
30190310
21.

Sexual steroid hormone receptors profiles of ovarian carcinoma in Mexican women.

Gómora MJ, Morales-Vásquez F, Pedernera E, Perez-Montiel D, López-Basave H, Villa AR, Hernández-Martínez A, Mena E, Mendez C.

Endocr Connect. 2018 Sep 1;7(9):1006-1012. doi: 10.1530/EC-18-0158.

22.
23.

A Prospective Comparison of 18F-Sodium Fluoride PET/CT and PSMA-Targeted 18F-DCFBC PET/CT in Metastatic Prostate Cancer.

Harmon SA, Bergvall E, Mena E, Shih JH, Adler S, McKinney Y, Mehralivand S, Citrin DE, Couvillon A, Madan RA, Gulley JL, Mease RC, Jacobs PM, Pomper MG, Turkbey B, Choyke PL, Lindenberg ML.

J Nucl Med. 2018 Nov;59(11):1665-1671. doi: 10.2967/jnumed.117.207373. Epub 2018 Mar 30.

24.

Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals.

Noureddin M, Wong MM, Todo T, Lu SC, Sanyal AJ, Mena EA.

World J Gastroenterol. 2018 Mar 21;24(11):1269-1277. doi: 10.3748/wjg.v24.i11.1269.

25.

Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent.

Plyku D, Mena E, Rowe SP, Lodge MA, Szabo Z, Cho SY, Pomper MG, Sgouros G, Hobbs RF.

Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):989-998. doi: 10.1007/s00259-018-3939-x. Epub 2018 Feb 19.

26.

Effect of Bacillus pumilus CCIBP-C5 on Musa-Pseudocercospora fijiensis interaction.

Cruz-Martín M, Acosta-Suárez M, Mena E, Roque B, Pichardo T, Alvarado-Capó Y.

3 Biotech. 2018 Feb;8(2):122. doi: 10.1007/s13205-018-1152-z. Epub 2018 Feb 9.

27.

The hypoparathyroidism-deafness-renal dysplasia syndrome: A case report.

Gogorza MS, Mena E, Serra G, Jiménez A, Noval M, Pereg V.

Endocrinol Diabetes Nutr. 2018 Mar;65(3):187-188. doi: 10.1016/j.endinu.2017.12.002. Epub 2018 Feb 3. English, Spanish. No abstract available.

PMID:
29398643
28.

Clinical impact of PSMA-based 18F-DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy.

Mena E, Lindenberg ML, Shih JH, Adler S, Harmon S, Bergvall E, Citrin D, Dahut W, Ton AT, McKinney Y, Weaver J, Eclarinal P, Forest A, Afari G, Bhattacharyya S, Mease RC, Merino MJ, Pinto P, Wood BJ, Jacobs P, Pomper MG, Choyke PL, Turkbey B.

Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):4-11. doi: 10.1007/s00259-017-3818-x. Epub 2017 Sep 11.

PMID:
28894899
29.

Precision Medicine and PET/Computed Tomography in Melanoma.

Mena E, Sanli Y, Marcus C, Subramaniam RM.

PET Clin. 2017 Oct;12(4):449-458. doi: 10.1016/j.cpet.2017.05.002. Epub 2017 Jul 14. Review.

30.

18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology.

Turkbey B, Mena E, Lindenberg L, Adler S, Bednarova S, Berman R, Ton AT, McKinney Y, Eclarinal P, Hill C, Afari G, Bhattacharyya S, Mease RC, Merino MJ, Jacobs PM, Wood BJ, Pinto PA, Pomper MG, Choyke PL.

Clin Nucl Med. 2017 Oct;42(10):735-740. doi: 10.1097/RLU.0000000000001804.

31.

Tricuspid valve replacement with mechanical prostheses: Short and long-term outcomes.

Rossello X, Muñoz-Guijosa C, Mena E, Camprecios M, Mendez AB, Borras X, Padro JM.

J Card Surg. 2017 Sep;32(9):542-549. doi: 10.1111/jocs.13193. Epub 2017 Aug 9.

PMID:
28795446
32.

Practical no-gold-standard evaluation framework for quantitative imaging methods: application to lesion segmentation in positron emission tomography.

Jha AK, Mena E, Caffo B, Ashrafinia S, Rahmim A, Frey E, Subramaniam RM.

J Med Imaging (Bellingham). 2017 Jan;4(1):011011. doi: 10.1117/1.JMI.4.1.011011. Epub 2017 Mar 3.

33.

Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).

Han MA, Saouaf R, Ayoub W, Todo T, Mena E, Noureddin M.

Expert Rev Clin Pharmacol. 2017 Apr;10(4):379-390. doi: 10.1080/17512433.2017.1299573. Epub 2017 Mar 9. Review.

34.

Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma.

Mena E, Taghipour M, Sheikhbahaei S, Jha AK, Rahmim A, Solnes L, Subramaniam RM.

Clin Nucl Med. 2017 May;42(5):e227-e234. doi: 10.1097/RLU.0000000000001578.

35.

Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.

Taghipour M, Mena E, Kruse MJ, Sheikhbahaei S, Subramaniam RM.

Nucl Med Commun. 2017 Mar;38(3):250-258. doi: 10.1097/MNM.0000000000000639.

36.

Imaging Locally Advanced, Recurrent, and Metastatic Prostate Cancer: A Review.

Lindenberg ML, Turkbey B, Mena E, Choyke PL.

JAMA Oncol. 2017 Oct 1;3(10):1415-1422. doi: 10.1001/jamaoncol.2016.5840. Review.

PMID:
28097325
37.

Confirmed clinical case of chronic kidney disease of nontraditional causes in agricultural communities in Central America: a case definition for surveillance.

Ferreiro A, Álvarez-Estévez G, Cerdas-Calderón M, Cruz-Trujillo Z, Mena E, Reyes M, Sandoval-Diaz M, Sánchez-Polo V, Valdés R, Ordúnez P.

Rev Panam Salud Publica. 2016 Nov;40(5):301-308.

PMID:
28076578
38.

Molecular Imaging and Precision Medicine in Head and Neck Cancer.

Mena E, Thippsandra S, Yanamadala A, Redy S, Pattanayak P, Subramaniam RM.

PET Clin. 2017 Jan;12(1):7-25. doi: 10.1016/j.cpet.2016.08.009. Epub 2016 Oct 5. Review.

PMID:
27863568
39.

Molecular Imaging and Precision Medicine: PET/Computed Tomography and Therapy Response Assessment in Oncology.

Sheikhbahaei S, Mena E, Pattanayak P, Taghipour M, Solnes LB, Subramaniam RM.

PET Clin. 2017 Jan;12(1):105-118. doi: 10.1016/j.cpet.2016.08.002. Epub 2016 Oct 5. Review.

PMID:
27863562
40.

Association between non-perfusion parameters and presence of ischemia in gated-SPECT myocardial perfusion imaging studies.

Peix A, Cabrera LO, Padrón K, Rodríguez L, Fernández J, López G, Carrillo R, Mena E, Fernández Y, Dondi M, Páez D.

J Nucl Cardiol. 2018 Apr;25(2):609-615. doi: 10.1007/s12350-016-0728-4. Epub 2016 Nov 17.

PMID:
27858344
41.

Advancement of MR and PET/MR in Prostate Cancer.

Lindenberg L, Ahlman M, Turkbey B, Mena E, Choyke P.

Semin Nucl Med. 2016 Nov;46(6):536-543. doi: 10.1053/j.semnuclmed.2016.07.001. Epub 2016 Sep 3. Review.

PMID:
27825433
42.

18F-FDG PET/CT Metabolic Tumor Volume and Intratumoral Heterogeneity in Pancreatic Adenocarcinomas: Impact of Dual-Time Point and Segmentation Methods.

Mena E, Sheikhbahaei S, Taghipour M, Jha AK, Vicente E, Xiao J, Subramaniam RM.

Clin Nucl Med. 2017 Jan;42(1):e16-e21.

43.

Clinical Indications and Impact on Management: Fourth and Subsequent Posttherapy Follow-up 18F-FDG PET/CT Scans in Oncology Patients.

Taghipour M, Marcus C, Sheikhbahaei S, Mena E, Prasad S, Jha AK, Solnes L, Subramaniam RM.

J Nucl Med. 2017 May;58(5):737-743. doi: 10.2967/jnumed.116.183111. Epub 2016 Nov 3.

44.

The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer.

Sheikhbahaei S, Mena E, Yanamadala A, Reddy S, Solnes LB, Wachsmann J, Subramaniam RM.

AJR Am J Roentgenol. 2017 Feb;208(2):420-433. doi: 10.2214/AJR.16.16532. Epub 2016 Oct 11. Review.

PMID:
27726427
45.

Evaluation of Prostate Cancer with PET/MRI.

Lindenberg L, Ahlman M, Turkbey B, Mena E, Choyke P.

J Nucl Med. 2016 Oct;57(Suppl 3):111S-116S. Review.

46.

JOURNAL CLUB: Value of Quantitative FDG PET/CT Volumetric Biomarkers in Recurrent Colorectal Cancer Patient Survival.

Marcus C, Wray R, Taghipour M, Marashdeh W, Ahn SJ, Mena E, Subramaniam RM.

AJR Am J Roentgenol. 2016 Aug;207(2):257-65. doi: 10.2214/AJR.15.15806.

PMID:
27447341
47.

FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.

Sheikhbahaei S, Trahan TJ, Xiao J, Taghipour M, Mena E, Connolly RM, Subramaniam RM.

Oncologist. 2016 Aug;21(8):931-9. doi: 10.1634/theoncologist.2015-0353. Epub 2016 Jul 8.

48.

18F-FDG PET/CT and Melanoma: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.

Mena E, Taghipour M, Sheikhbahaei S, Mirpour S, Xiao J, Subramaniam RM.

Clin Nucl Med. 2016 Sep;41(9):e403-9. doi: 10.1097/RLU.0000000000001275.

PMID:
27355846
49.

The Current and Evolving Role of PET in Personalized Management of Lung Cancer.

Mena E, Yanamadala A, Cheng G, Subramaniam RM.

PET Clin. 2016 Jul;11(3):243-59. doi: 10.1016/j.cpet.2016.02.010. Epub 2016 May 2. Review.

PMID:
27321029
50.

PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.

Rowe SP, Macura KJ, Mena E, Blackford AL, Nadal R, Antonarakis ES, Eisenberger M, Carducci M, Fan H, Dannals RF, Chen Y, Mease RC, Szabo Z, Pomper MG, Cho SY.

Mol Imaging Biol. 2016 Jun;18(3):411-9. doi: 10.1007/s11307-016-0957-6.

Supplemental Content

Support Center